62 related articles for article (PubMed ID: 28762281)
1. Clinical significance of farnesoid X receptor expression in thyroid neoplasia.
Giaginis C; Tsoukalas N; Alexandrou P; Tsourouflis G; Dana E; Delladetsima I; Patsouris E; Theocharis S
Future Oncol; 2017 Aug; 13(20):1785-1792. PubMed ID: 28762281
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions.
Lakiotaki E; Giaginis C; Tolia M; Alexandrou P; Delladetsima I; Giannopoulou I; Kyrgias G; Patsouris E; Theocharis S
Biomed Res Int; 2015; 2015():839403. PubMed ID: 26539529
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Poulaki E; Delladetsima I; Troungos C; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Apr; 22(2):269-75. PubMed ID: 26220827
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions.
Giaginis C; Zarros A; Alexandrou P; Klijanienko J; Delladetsima I; Theocharis S
APMIS; 2010 Mar; 118(3):210-21. PubMed ID: 20132187
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.
Giaginis C; Alexandrou P; Delladetsima I; Giannopoulou I; Patsouris E; Theocharis S
Tumour Biol; 2014 Jan; 35(1):61-71. PubMed ID: 23873102
[TBL] [Abstract][Full Text] [Related]
7. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
9. Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer.
Wang W; Yin X; Li G; Yi J; Wang J
Chin Med J (Engl); 2014; 127(14):2637-42. PubMed ID: 25043081
[TBL] [Abstract][Full Text] [Related]
10. Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma.
Giaginis C; Koutsounas I; Alexandrou P; Zizi-Serbetzoglou A; Patsouris E; Kouraklis G; Theocharis S
Neoplasma; 2015; 62(2):332-41. PubMed ID: 25591600
[TBL] [Abstract][Full Text] [Related]
11. Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study.
Karidis NP; Giaginis C; Tsourouflis G; Alexandrou P; Delladetsima I; Theocharis S
Med Sci Monit; 2011 Sep; 17(9):BR257-65. PubMed ID: 21873938
[TBL] [Abstract][Full Text] [Related]
12. Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.
Fu G; Polyakova O; MacMillan C; Ralhan R; Walfish PG
EBioMedicine; 2017 Apr; 18():50-55. PubMed ID: 28363612
[TBL] [Abstract][Full Text] [Related]
13. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions.
Giaginis C; Demetriou N; Alexandrou P; Stolakis V; Delladetsima I; Klijanienko J; Griniatsos I; Theocharis S
Med Sci Monit; 2012 Apr; 18(4):BR123-9. PubMed ID: 22460085
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma.
Cheng SP; Chi CW; Tzen CY; Yang TL; Lee JJ; Liu TP; Liu CL
Surgery; 2010 Jun; 147(6):847-53. PubMed ID: 20045163
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
19. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
20. Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.
Lax S; Schauer G; Prein K; Kapitan M; Silbert D; Berghold A; Berger A; Trauner M
Int J Cancer; 2012 May; 130(10):2232-9. PubMed ID: 21780109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
